1. Impact of Neoadjuvant Chemotherapy on Post-Operative Outcomes of Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma: ACS-NSQIP Propensity-Matched Analysis. (2022) Authors: Choi, W.J.; Ivanics, T.; Claasen, M.; Murillo, F.; Gallinger, S.; Hansen, B.; Sapisochin, G. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preoperative Neutrophil-To-Lymphocyte Ratio Is Prognostic for Early Recurrence after Curative Intrahepatic Cholangiocarcinoma Resection. (2022) Authors: Choi, W.J.; Murillo, F.; Gravely, A.; Claasen, M.; Ivanics, T.; Abraham, L.; Abreu, P.; Visser, R.; Gallinger, S.; Hansen, B.; Sapisochin, G. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preoperative neutrophil-to-lymphocyte ratio is prognostic for recurrence within the first 12 months after curative intrahepatic cholangiocarcinoma resection. (2021) Authors: Choi, W.J.; Choi, W.J.; Murillo, F.; Gravely, A.; Claasen, M.; Ivanic, T.; Abraham, L.; Abreu, P.; Visser, R.; Hansen, B.; Sapisochin, G. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗